Quick Nav
Publications
Pharmacy Times
GI Watch

Experts Reach Consensus on IBS Management

Published Online: Sunday, June 1, 2003   [ Request Print ]

Irritable bowel syndrome (IBS) is among the most common disorders gastroenterol-ogists and primary care physicians encounter. In the past 10 years, research strides have radically changed how patients with IBS are diagnosed and treated.

Late last year the American College of Gastroenterology Functional Gastrointestinal Disorders Task Force developed a consensus document, An Evidence-Based Position Statement and Systematic Review on the Management of IBS in North America, which was published as a supplement to the American Journal of Gastroenterology. The aim of this document is to equip physicians with practical resources they can use to diagnose, treat, and manage IBS patients in their clinical practices.

The task force gave the highest recommendations (based on supporting evidence and quality of clinical trials) to the only 2 approved treatments for the multiple symptoms of IBS:

  • Tegaserod, indicated for the short-term treatment of women with IBS whose primary bowel symptom is constipation, and
  • Alosetron, indicated for the treatment of women with severe diarrhea-predominant IBS who have failed conventional IBS therapy.
Related Articles
No Result Found




Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.
 




Become a Member
Forgot Password?